期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
基于固定化酶的乙酰胆碱酯酶抑制剂体外筛选模型的建立 被引量:1
1
作者 陈晨 史倩 +4 位作者 陈军辉 张茹潭 李鑫 郑立 王小如 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2013年第5期1121-1126,共6页
以可重复使用的固定化酶代替游离态酶,建立一种基于比色分析的乙酰胆碱酯酶(AChE)抑制剂体外筛选新模型.采用以氨基化硅胶为载体固定的AChE优化了实验条件,用AChE抑制剂阳性对照物他克林和毒扁豆碱对该模型进行验证,还对模型技术参数进... 以可重复使用的固定化酶代替游离态酶,建立一种基于比色分析的乙酰胆碱酯酶(AChE)抑制剂体外筛选新模型.采用以氨基化硅胶为载体固定的AChE优化了实验条件,用AChE抑制剂阳性对照物他克林和毒扁豆碱对该模型进行验证,还对模型技术参数进行评价,并将新模型用于单体化合物及天然产物粗提物AChE抑制活性评价.结果表明,最佳实验条件为:固定化酶用量55μL,底物浓度5 mmol/L,甲醇、乙醇及体积分数不高于6%的二甲基亚砜水溶液均可作为样品溶剂;模型验证及模型技术参数评价结果良好,该模型对AChE抑制剂筛选有较好的特异性和灵敏度,可用于筛选AChE抑制剂.该模型具有适用性强、固定化酶可重复使用及结果可靠等优点,是单体化合物及天然产物粗提物AChE抑制剂活性评价的有效方法. 展开更多
关键词 固定化 乙酰胆碱酯抑制 酶抑制剂筛选
下载PDF
微流控技术筛选酶抑制剂的研究进展 被引量:2
2
作者 简文思 韩丽萍 陈缵光 《化学研究与应用》 CAS CSCD 北大核心 2014年第12期1825-1830,共6页
随着近年新合成或提取的化合物大量涌现,药物筛选朝着快速、高效、高通量方向发展。微流控分析技术具有的分析微型化、高通量化、可集成化和良好的生物相容性等特点,为药物的筛选提供了新的方法和技术平台。本文简要介绍了酶抑制剂筛选... 随着近年新合成或提取的化合物大量涌现,药物筛选朝着快速、高效、高通量方向发展。微流控分析技术具有的分析微型化、高通量化、可集成化和良好的生物相容性等特点,为药物的筛选提供了新的方法和技术平台。本文简要介绍了酶抑制剂筛选,重点评述基于微流控技术筛选酶抑制剂的研究进展。 展开更多
关键词 微流控芯片 药物筛选 酶抑制剂筛选 液滴微流控系统
下载PDF
Computational Screening of Novel Mitogen-activated Protein Kinase Kinase-1 (MEK1) Inhibitors by Docking and Scoring
3
作者 Po-Yuan Chen Hong-Jye Hong +7 位作者 Mien-De Jhuo Tzu-Hurng Cheng Wei-Tse Hsu Chieh-Hsi Wu Che-YenOu Yeng-Ting Yui Jing-Pin Lin Jing-Gung Chung 《Journal of Life Sciences》 2011年第6期434-442,共9页
The mitogen-activated protein kinase (MAPK) cell signal transduction pathways play a key role in determining the survival of cells. If these pathways can be controlled, they will prohibit the proliferation of cancer... The mitogen-activated protein kinase (MAPK) cell signal transduction pathways play a key role in determining the survival of cells. If these pathways can be controlled, they will prohibit the proliferation of cancer cells. To attain this goal, the authors utilize many drugs to interact with mitogen-activated protein kinase kinase-1 (MEK1) in MAPK, and use computer aided drug design (CADD) to analyze the ligand activities of proteins in MEKL The results show that in these drugs, the aromatic group in the terminal of the protein and the PHE209 will induce the stacking force, which is highly related to the actual activities of these drugs. 展开更多
关键词 Docking and scoring computational screening mitogen-activated protein kinase kinase-1 (MEK1).
下载PDF
沙棘粗多糖对α-葡萄糖苷酶活性影响及酶动力学的研究 被引量:7
4
作者 曾阳 郭凤霞 +1 位作者 陈振宁 马继雄 《药物分析杂志》 CAS CSCD 北大核心 2012年第12期2154-2157,共4页
目的:探讨中国沙棘粗多糖中α-葡萄糖苷酶抑制剂的体外酶动力学的特性。方法:利用酶-抑制剂筛选模型,选择沙棘粗多糖,通过改变其浓度、反应时间、pH条件、温度等进行体外酶学动力学研究。结果:沙棘粗多糖浓度在0.0098~0.625 g.L-1之间... 目的:探讨中国沙棘粗多糖中α-葡萄糖苷酶抑制剂的体外酶动力学的特性。方法:利用酶-抑制剂筛选模型,选择沙棘粗多糖,通过改变其浓度、反应时间、pH条件、温度等进行体外酶学动力学研究。结果:沙棘粗多糖浓度在0.0098~0.625 g.L-1之间时,酶的抑制率随着浓度的增大而升高,IC50为0.031 g.L-1;浓度为0.625 g.L-1时抑制率达92.52%,且与酶结合迅速,酸碱范围广,热稳定性好。结论:沙棘粗多糖是一种高活性的竞争可逆性α-葡萄糖苷酶抑制剂,抑制常数Ki=5.26g.L-1。 展开更多
关键词 Α-葡萄糖苷 抑制 沙棘粗多糖 -抑制筛选模型 动力学
原文传递
Sphingomyelin synthase activity measurement by the fluorescent product in cell culture medium or animal plasma 被引量:1
5
作者 丁庭波 董继斌 +1 位作者 楼滨 蒋宪成 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2014年第4期256-261,共6页
Sphingolipids, a new class of lipid mediators, are involved in a variety of important physiological and pathological processes. Sphingomyelin synthase (SMS) is an enzyme to convert the ceramide (Cer.) and phosphat... Sphingolipids, a new class of lipid mediators, are involved in a variety of important physiological and pathological processes. Sphingomyelin synthase (SMS) is an enzyme to convert the ceramide (Cer.) and phosphatidylcholine into sphingomyelin (SM) and diacylglycerol, which plays a key role in sphingolipid biosynthesis. Two SMS isoforms, SMS1 and SMS2, have been identified with different subceUular localizations and expression level in tissues. Previous studies have shown that SMS may serve as a potential therapeutic target for the treatment of various diseases, such as cardiovascular and metabolic diseases. Thus, there is an urgent need for a rapid and sensitive method for SMS activity analysis. In our study, we developed a novel method for SMS activity by monitoring the appearance of the product, NBD-SM, in the tissue culture medium or blood and applied this method in cells and mice. In Huh7 cells, the interassay coefficient of variation of the SMS activity assay was (3.60±0.07)% . In wild type (WT) mice, we observed accumulation of NBD-SM in blood in a time dependent fashion. In SMS2 KO mice, NBD-SM in plasma collected at 5- (0%, P〈0.01), 30- (16%, P〈0.01), and 60 min (21%, P〈0.01) after injection of fluorescence liposome solution was significantly decreased compared with WT mice. However, in SMS1 KO mice, NBD-SM in plasma collected 5- and 30 min is similar to that in WT mice. Our results suggest that this method could be used for SMS activity measurement in vitro and in vivo. 展开更多
关键词 Sphingomyelin synthase SMS activity assay SMS inhibitor screening SPHINGOMYELIN CERAMIDE
原文传递
Virtual screening and high-throughput testing of L1 metallo-β-lactamase inhibitor
6
作者 Chennan Liu Qian Wang +9 位作者 Jiangxue Han Sihan Liu Chunling Xiao Yan Guan Xinghua Li Ying Wang Xiao Wang Jianzhou Meng Maoluo Gan Yishuang Liu 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第10期806-812,共7页
As a zinc-dependent enzyme, metal-β-lactamase L1 contributes to the development of β-lactam antibiotic resistance. The metal-β-lactamase inhibitor can restore the efficacy of β-lactam antibiotics, and its developm... As a zinc-dependent enzyme, metal-β-lactamase L1 contributes to the development of β-lactam antibiotic resistance. The metal-β-lactamase inhibitor can restore the efficacy of β-lactam antibiotics, and its development has attracted much attention. In the present study, we used four widely-used virtual screening programs to screen 7035 small molecules to identify potential L1 inhibitors, and a high-throughput experimental model of L1 inhibitors was established. In this high-throughput testing model, the inhibition rate of 163 compounds on L1 exceeded 40%. The results of virtual screening of 7035 small molecules using the following four programs showed that among the top 1.35% of the compounds, their hit rates were ranked as Schr?dinger’s(5.26%), DS(1.05%), and Sybyl-x 2.0(1.05%), and Smina(2.11%). 展开更多
关键词 L1 Metallo-beta-lactamase inhibitor Virtual screening High-throughput screening
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部